BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37325062)

  • 1. Differences between Advanced Large Cell Neuroendocrine Carcinoma and Advanced Small Cell Lung Cancer: A Propensity Score Matching Analysis.
    Yang W; Wang W; Li Z; Wu J; Xu X; Chen C; Ye X
    J Cancer; 2023; 14(9):1541-1552. PubMed ID: 37325062
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence, survival comparison, and novel prognostic evaluation approaches for stage iii-iv pulmonary large cell neuroendocrine carcinoma and small cell lung cancer.
    Huang L; Feng Y; Xie T; Zhu H; Tang L; Shi Y
    BMC Cancer; 2023 Apr; 23(1):312. PubMed ID: 37020179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of large cell neuroendocrine carcinoma and small cell lung carcinoma in high-grade neuroendocrine tumors of the lung: a large population-based study.
    Wang J; Ye L; Cai H; Jin M
    J Cancer; 2019; 10(18):4226-4236. PubMed ID: 31413741
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.
    Wang Y; Qian F; Chen Y; Yang Z; Hu M; Lu J; Zhang Y; Zhang W; Cheng L; Han B
    Front Oncol; 2021; 11():714549. PubMed ID: 34631540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for Surgery in Stage IA Large Cell Lung Neuroendocrine Compared With Other Types of Non-Small Cell Lung Cancer: A Propensity Score Matching Study Based on the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zou L; Guo T; Ye L; Zhou Y; Chu L; Chu X; Ni J; Zhu Z; Yang X
    Front Oncol; 2020; 10():572462. PubMed ID: 33324549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
    Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
    Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung.
    Fujiwara W; Yotsukura M; Yoshida Y; Nakagawa K; Kashima J; Yatabe Y; Watanabe SI
    Ann Surg Oncol; 2024 May; ():. PubMed ID: 38811497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
    Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
    Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of perioperative chemotherapy for pulmonary high-grade neuroendocrine carcinomas: a propensity score matching analysis.
    Ogawa H; Tanaka Y; Kitamura Y; Shimizu N; Doi T; Hokka D; Tane S; Nishio W; Yoshimura M; Maniwa Y
    J Thorac Dis; 2019 Apr; 11(4):1145-1154. PubMed ID: 31179056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
    Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
    Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of large cell neuroendocrine carcinoma: a population-based overview.
    Derks JL; Hendriks LE; Buikhuisen WA; Groen HJ; Thunnissen E; van Suylen RJ; Houben R; Damhuis RA; Speel EJ; Dingemans AM
    Eur Respir J; 2016 Feb; 47(2):615-24. PubMed ID: 26541538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.
    Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q
    Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-cell neuroendocrine carcinoma of the gynecologic tract: Prevalence, survival outcomes, and associated factors.
    Pang L; Chen J; Chang X
    Front Oncol; 2022; 12():970985. PubMed ID: 36457506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of radiotherapy in pulmonary large cell neuroendocrine carcinoma: propensity score matching analysis.
    Cao L; Wu HF; Zhao L; Bai Y; Jiang ZL; Yang WJ; Liu SX
    J Radiat Res; 2020 Jul; 61(4):594-601. PubMed ID: 32567658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival After Lobectomy vs. Sublobar Resection for Stage IA Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
    Yu X; Zhang M; Wang F; Guo X; Ma K; Wang L; Zhao H; Xiao H; Huang C; Du L; Jia R; Yang Y; Zhang L; Yu Z
    Front Surg; 2022; 9():856048. PubMed ID: 35372493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes for localized treatment of large cell neuroendocrine carcinoma of the lung in the United States.
    May MS; Kinslow CJ; Adams C; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
    Transl Lung Cancer Res; 2021 Jan; 10(1):71-79. PubMed ID: 33569294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma.
    Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of surgery in high grade neuroendocrine tumours of the lung.
    Welter S; Aigner C; Roesel C
    J Thorac Dis; 2017 Nov; 9(Suppl 15):S1474-S1483. PubMed ID: 29201450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.